IFNL3 (IL28B) variation rs12979860

From Aaushi

Jump to navigation Jump to search

^[1]

Indications

hepatitis C genotype 1 infection

Clinical significance

IFNL3 (IL28B) variation (rs12979860) is the strongest baseline predictor of response to PEG-interferon-alpha- containing regimens in HCV genotype 1 patients^[1]

More general terms

gene mutation testing; gene mutation analysis

References

↑ ^{Jump up to: 1.0} ^1.1 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline information for boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir and IFNL3. https://www.pharmgkb.org/guideline/PA166110235

Retrieved from "https://aaushi.info/w/index.php?title=A50537&oldid=1027033"

↑ Back to top